Bromhexine

Bromhexine

SCHEMBL99613

CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1.Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Bromhexine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 known ✓ P31645 2/20 0.97
▸ KCNH2 known ✓ Q12809 2/20 0.97
▸ SLC6A2 known ✓ P23975 1/20 0.97
▸ PDE4A known ✓ P27815 1/20 0.97
▸ SLC6A3 known ✓ Q01959 1/20 0.97
▸ SIGMAR1 known ✓ Q99720 1/20 0.97
▸ HRH3 known ✓ Q9Y5N1 2/20 0.42
▸ HRH2 known ✓ P25021 1/20 0.41
▸ NTRK1 known ✓ P04629 1/20 0.36
▸ RET known ✓ P07949 1/20 0.36
▸ MET known ✓ P08581 1/20 0.36
▸ PDGFRB known ✓ P09619 1/20 0.36
▸ FGFR1 known ✓ P11362 1/20 0.36
▸ PDGFRA known ✓ P16234 1/20 0.36
▸ FLT3 known ✓ P36888 1/20 0.36
▸ PRKCQ known ✓ Q04759 1/20 0.36
▸ ROCK1 known ✓ Q13464 1/20 0.36
▸ NTRK3 known ✓ Q16288 1/20 0.36
▸ ALK known ✓ Q9UM73 1/20 0.36
▸ LMNA P02545 4/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromhexine SCHEMBL10704011 1.00 LMNA (1.00) LMNACYP3A4HTTCYP2D6SLC6A4
Bromhexine SCHEMBL19059 0.99 CYP2D6 (1.00) LMNACYP3A4HTTCYP2D6SLC6A4
Bromhexine SCHEMBL29379593 0.99 CYP2D6 (1.00) LMNACYP3A4HTTCYP2D6SLC6A4
Bromhexine SCHEMBL18548828 0.97 CYP2D6 (0.97) LMNACYP3A4HTTCYP2D6SLC6A4
Bromhexine SCHEMBL8573766 0.89 CYP2D6 (0.81) LMNACYP3A4HTTCYP2D6SLC6A4
Bromhexine SCHEMBL5968149 0.89 CYP2D6 (0.81) LMNACYP3A4HTTCYP2D6SLC6A4
SCHEMBL13907693 0.87 CYP2D6 (0.79) LMNACYP3A4HTTCYP2D6SLC6A4
Hydrochloric Acid SCHEMBL30080244 0.86 LMNA (0.76) LMNACYP3A4HTTCYP2D6SLC6A4
Hydrochloric Acid SCHEMBL28598338 0.86 CYP3A4 (0.76) LMNACYP3A4HTTCYP2D6SLC6A4
Hydrochloric Acid SCHEMBL11879112 0.86 LMNA (0.76) LMNACYP3A4HTTCYP2D6SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2560 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122056843-A Bromhexine hydrochloride sustained-release micro tablet and preparation process thereof 苏州弘森药业股份有限公司 2026-05-19 — — CN claimed
CN-122055143-A Solid compositions containing bromhexine 第一三共健康事业株式会社 2026-05-15 — — CN claimed
US-12539282-B2 Bromhexine for the treatment of pain KERN KAI UWE (DE) 2026-02-03 — — US claimed
US-20250269005-A1 METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT TOPELIA AUST LIMITED (ACN 652 771 670) (AU) 2025-08-28 — — US claimed
WO-2025100462-A1 SOLID COMPOSITION CONTAINING BROMHEXINE 第一三共ヘルスケア株式会社 2025-05-15 — — WO claimed
CN-119857073-A Bromhexine hydrochloride oral solution 江苏广承药业有限公司 2025-04-22 — — CN claimed
CN-119837825-A Compound enrofloxacin injection, preparation method and content determination method thereof 重庆方通动物药业有限公司 2025-04-18 — — CN claimed
CN-115980202-B High performance liquid chromatography detection method for bromhexine hydrochloride crude drug related substances 山东齐都药业有限公司 2025-03-28 — — CN claimed
CN-119606932-A Bromhexine hydrochloride composition and preparation method thereof 天津市中升挑战生物科技有限公司 2025-03-14 — — CN claimed
CN-119504447-A Preparation method of bromhexine hydrochloride 浙江海洲制药股份有限公司 2025-02-25 — — CN claimed
CN-1411806-A Bromhexine hydrochloride injection and its preparation method NANCHANG YIBO MEDICINE SCIENCE (CN) 2003-04-23 — — CN claimed
CN-1276246-A Process for preparing medicines with no or low loxic by-effect on gastrointestinal system WANG XIAO (CN) 2000-12-13 — — CN claimed
EP-0583358-B1 PARTIAL LIQUID BREATHING OF FLUOROCARBONS ALLIANCE PHARMA (US) 1998-12-02 — — EP claimed
US-5811547-A Method for inducing crystalline state transition in medicinal substance NIPPON SHINYAJU CO., LTD. (JP) 1998-09-22 — — US claimed
US-5700410-A Method of manufacturing wax matrices NIPPON SHINYAKU CO., LTD. (JP) 1997-12-23 — — US claimed
CN-1036339-C Method of preparing N-methylcyclohexylamine as raw material of bromocaproic hydrochloride medicine JINTAN CITY ASSISTANTS FACTORY (CN) 1997-11-05 — — CN claimed
EP-0580860-B1 METHOD OF MANUFACTURING SOLID DISPERSION NIPPON SHINYAKU CO LTD (JP) 1997-10-22 — — EP claimed
CN-1092062-A The production method of the raw material N-methylcyclohexylamine of bromhexine hydrochloride medicine JINTAN COUNTY ASSISTANTS FACTO (CN) 1994-09-14 — — CN claimed
EP-0125634-B1 USE OF A SECRETOLYTICALLY ACTIVE SUBSTANCE FOR THE MANUFACTURE OF A REMEDY AGAINST SNORING AND FOR COMBATING SNORE PHENOMENON Reichert, Dietrich, Dr. med. (ES) 1990-09-26 — — EP claimed
EP-0125634-A1 Use of a secretolytically active substance for the manufacture of a remedy against snoring and for combating snore phenomenon Reichert, Dietrich, Dr. med. (ES) 1984-11-21 — — EP claimed
Send feedback